KRAS and cancer: Second, most cancer cells have a defective G1 checkpoint made dysfunctional by mutations in regulators of the G1/S transition (K-Ras, p16 and p53, etc.)[90], thereby making these cells more reliant on the G2 checkpoint for radioprotection.